1. Home
  2. DJCO vs SAGE Comparison

DJCO vs SAGE Comparison

Compare DJCO & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DJCO
  • SAGE
  • Stock Information
  • Founded
  • DJCO 1987
  • SAGE 2010
  • Country
  • DJCO United States
  • SAGE United States
  • Employees
  • DJCO N/A
  • SAGE N/A
  • Industry
  • DJCO Newspapers/Magazines
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • DJCO Consumer Discretionary
  • SAGE Health Care
  • Exchange
  • DJCO Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • DJCO 569.1M
  • SAGE 571.1M
  • IPO Year
  • DJCO N/A
  • SAGE 2014
  • Fundamental
  • Price
  • DJCO $389.45
  • SAGE $9.19
  • Analyst Decision
  • DJCO
  • SAGE Hold
  • Analyst Count
  • DJCO 0
  • SAGE 18
  • Target Price
  • DJCO N/A
  • SAGE $9.89
  • AVG Volume (30 Days)
  • DJCO 87.7K
  • SAGE 3.1M
  • Earning Date
  • DJCO 08-13-2025
  • SAGE 07-30-2025
  • Dividend Yield
  • DJCO N/A
  • SAGE N/A
  • EPS Growth
  • DJCO 375.38
  • SAGE N/A
  • EPS
  • DJCO 76.72
  • SAGE N/A
  • Revenue
  • DJCO $73,247,000.00
  • SAGE $47,404,000.00
  • Revenue This Year
  • DJCO N/A
  • SAGE $102.21
  • Revenue Next Year
  • DJCO N/A
  • SAGE $43.01
  • P/E Ratio
  • DJCO $5.24
  • SAGE N/A
  • Revenue Growth
  • DJCO 1.99
  • SAGE N/A
  • 52 Week Low
  • DJCO $359.34
  • SAGE $4.62
  • 52 Week High
  • DJCO $602.00
  • SAGE $13.47
  • Technical
  • Relative Strength Index (RSI)
  • DJCO 39.47
  • SAGE 71.99
  • Support Level
  • DJCO $418.00
  • SAGE $9.10
  • Resistance Level
  • DJCO $443.50
  • SAGE $9.22
  • Average True Range (ATR)
  • DJCO 14.47
  • SAGE 0.12
  • MACD
  • DJCO -2.39
  • SAGE -0.03
  • Stochastic Oscillator
  • DJCO 3.38
  • SAGE 48.28

About DJCO Daily Journal Corp. (S.C.)

Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: